Mechanistic studies examine its interactions with nitric oxide signaling, prostaglandin pathways, and gastrointestinal dopamine and serotonin turnover, including their relevance to experimental models of intestinal inflammation and gastrointestinal dysfunction
Because the ratio is fixed at manufacture, a researcher working with GLOW is always working with all three compounds simultaneously and cannot isolate the contribution of any one of them
Not a drug, not a dietary supplement, not a cosmetic, not a food product, not for human or veterinary use, consumption, or ingestion
All evidence indicates that topical GHK-Cu application is a better choice
Practical risk-reduction steps Start with a good history